Skip to main content
Medical information Clinical review pending

Gastroenterology Testing

HLA Celiac Disease DRDQB1DQA1 Haplotype Association Including DQ2DQ8 Test

Genetic test to identify HLA haplotypes (DQ2/DQ8) associated with celiac disease risk. Helps in diagnosis and management of this autoimmune condition triggered by gluten.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
4 mL (3 mL minimum) whole blood in one Lavender Top (EDTA) tube or 6 mL (3 mL minimum) whole blood in one Yellow Top (ACD) tube.
Results
Results are typically available within one week. Confirm with the laboratory before booking.
Preparation
No special preparation is required for this test. Patients can eat and drink normally before sample collection.
Test priceKSh 16,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the HLA Celiac Disease DRDQB1DQA1 Haplotype Association Including DQ2DQ8 Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Individuals experiencing symptoms suggestive of celiac disease (e.g., chronic diarrhea, weight loss, bloating, fatigue).
  • ✓Individuals with a first-degree relative diagnosed with celiac disease.
  • ✓Individuals with other autoimmune conditions.
  • ✓Assisting in the diagnostic workup for suspected celiac disease.
  • ✓Ruling out celiac disease in individuals with ambiguous symptoms.
02

In plain language

What this test helps you understand

This genetic test helps assess an individual's predisposition to celiac disease by identifying the presence of HLA-DQ2 and HLA-DQ8 haplotypes. It aids in diagnostic evaluation, particularly when clinical symptoms are present or there is a family history of celiac disease. A negative result can help rule out celiac disease.
The HLA Celiac Disease DRDQB1DQA1 Haplotype Association Including DQ2DQ8 Test is a specialized genetic analysis used to identify specific human leukocyte antigen (HLA) haplotypes linked to an increased risk of developing celiac disease. Celiac disease is an autoimmune disorder where the ingestion of gluten leads to damage in the small intestine. This test looks for the presence of the HLA-DQ2 and HLA-DQ8 haplotypes, which are found in the vast majority of individuals with celiac disease.

Understanding your genetic predisposition to celiac disease can be important for early diagnosis and management. While a positive result indicates a higher risk, it does not confirm the diagnosis of celiac disease. Conversely, a negative result makes celiac disease highly unlikely. This test is often used alongside other diagnostic methods, such as antibody testing and biopsy, as recommended by a healthcare provider.

This test is particularly useful for individuals experiencing symptoms suggestive of celiac disease or those with a family history of the condition. Early diagnosis allows for the implementation of a gluten-free diet, which is the primary treatment and can prevent long-term complications.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is required for this test. Patients can eat and drink normally before sample collection.
Sample4 mL (3 mL minimum) whole blood in one Lavender Top (EDTA) tube or 6 mL (3 mL minimum) whole blood in one Yellow Top (ACD) tube.
MethodologyGenetic analysis using molecular techniques to detect specific HLA-DQ2 and HLA-DQ8 haplotypes.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
A positive result indicates a genetic predisposition but does not confirm a diagnosis of celiac disease. A negative result makes celiac disease highly unlikely but does not completely exclude it in rare cases. Results should be interpreted by a qualified healthcare professional.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Celiac disease is an autoimmune disorder where eating gluten damages the small intestine. It is not an allergy or intolerance.
No, a positive result indicates a genetic predisposition or increased risk. Further testing, like antibody tests or a biopsy, is needed for diagnosis.
A negative result means you do not have the common genetic markers for celiac disease, making the condition highly unlikely.
No, this is a genetic test and does not require dietary changes before sample collection.
A blood sample is drawn from your arm.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp